Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

INBX holding history

Inhibrx Biosciences, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

INBX overviewAll 13F holders of INBXFull Q4 2025 holdings

Shares (Q4 2025)
623,084
Value
$49.2M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of INBX by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 2025623,084$49.2M<0.1%+28,166+4.7%AddedHolders
Q3 2025594,918$20.0M<0.1%−3,530−0.6%ReducedHolders
Q2 2025598,448$8.54M<0.1%+10,125+1.7%AddedHolders
Q1 2025588,323$8.23M<0.1%−19,398−3.2%ReducedHolders
Q4 2024607,721$9.36M<0.1%+77,663+14.7%AddedHolders
Q3 2024530,058$8.30M<0.1%+52,030+10.9%AddedHolders
Q2 2024478,028$6.77M<0.1%−1,383,441−74.3%ReducedHolders
Q1 20241,861,469$65.1M<0.1%−12,854−0.7%ReducedHolders
Q4 20231,874,323$71.2M<0.1%+84,512+4.7%AddedHolders
Q3 20231,789,811$32.8M<0.1%+18,271+1.0%AddedHolders
Q2 20231,771,540$46.0M<0.1%−3,741−0.2%ReducedHolders
Q1 20231,775,281$33.5M<0.1%+14,908+0.8%AddedHolders
Q4 20221,760,373$43.4M<0.1%+292,455+19.9%AddedHolders
Q3 20221,467,918$26.3M<0.1%+111,802+8.2%AddedHolders
Q2 20221,356,116$15.4M<0.1%+138,003+11.3%AddedHolders
Q1 20221,218,113$27.1M<0.1%+11,365+0.9%AddedHolders
Q4 20211,206,748$52.7M<0.1%+527,223+77.6%AddedHolders
Q3 2021679,525$22.6M<0.1%+184,676+37.3%AddedHolders
Q2 2021494,849$13.6M<0.1%+107,957+27.9%AddedHolders
Q1 2021386,892$7.76M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.